MAS vs ORMP
Masco Corporation (MAS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MAS and ORMP stock pages for the full models.
Not investment advice.